{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:32:07Z","timestamp":1792146727786,"version":"4.4.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Lambert Initiative for Cannabinoid Therapeutics"},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Government Research Training Program"},{"name":"Vice-Chancellor\u2019s Research Scholarship (VCRS) at the University of Sydney"},{"name":"Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney"},{"name":"Dementia Research Development Fellowship of the Australian National Health and Medical Research Council-Australian Research Council","award":["APP1104003"],"award-info":[{"award-number":["APP1104003"]}]},{"name":"NHMRC Senior Principal Research Fellowship","award":["APP1106974"],"award-info":[{"award-number":["APP1106974"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Reviews"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.smrv.2020.101339","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T03:01:25Z","timestamp":1589598085000},"page":"101339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"special_numbering":"C","title":["Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5993-2246","authenticated-orcid":false,"given":"Anastasia S.","family":"Suraev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel S.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Vandrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7783-5220","authenticated-orcid":false,"given":"Danielle","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5777-0976","authenticated-orcid":false,"given":"Melissa J.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9307-7159","authenticated-orcid":false,"given":"Iain S.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R.","family":"Grunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla M.","family":"Hoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smrv.2020.101339_bib1","series-title":"Effects of sleep deficiency on hormones, cytokines, and metabolism. Impact of sleep and sleep disturbances on obesity and cancer","first-page":"25","author":"Buxton","year":"2014"},{"key":"10.1016\/j.smrv.2020.101339_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.smrv.2017.12.003","article-title":"A\u00a0systematic review and meta-analysis of cognitive and behavioral interventions to improve sleep health in adults without sleep disorders","volume":"40","author":"Murawski","year":"2018","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2020.101339_bib3","volume":"vol. 65","author":"Liu","year":"2016"},{"issue":"8","key":"10.1016\/j.smrv.2020.101339_bib4","doi-asserted-by":"crossref","first-page":"zsy083","DOI":"10.1093\/sleep\/zsy083","article-title":"The economic cost of inadequate sleep","volume":"41","author":"Hillman","year":"2018","journal-title":"Sleep"},{"issue":"1\u20133","key":"10.1016\/j.smrv.2020.101339_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jad.2011.01.011","article-title":"Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies","volume":"135","author":"Baglioni","year":"2011","journal-title":"J\u00a0Affect Disord"},{"issue":"6","key":"10.1016\/j.smrv.2020.101339_bib6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.smrv.2009.04.001","article-title":"Obstructive sleep apnea and depression","volume":"13","author":"Harris","year":"2009","journal-title":"Sleep Med Rev"},{"issue":"6","key":"10.1016\/j.smrv.2020.101339_bib7","doi-asserted-by":"crossref","first-page":"zsy047","DOI":"10.1093\/sleep\/zsy047","article-title":"Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: sleep Heart Health Study","volume":"41","author":"Bertisch","year":"2018","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.smrv.2020.101339_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1513\/pats.200708-143MG","article-title":"Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension","volume":"5","author":"Golbin","year":"2008","journal-title":"Proc Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.smrv.2020.101339_bib9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2174\/1871527315666160518123930","article-title":"Obstructive sleep apnea syndrome: an emerging risk factor for dementia","volume":"15","author":"Buratti","year":"2016","journal-title":"CNS Neurol Disord - Drug Targets"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12888-018-1623-0","article-title":"Risk of dementia in patients with primary insomnia: a nationwide population-based case-control study","volume":"18","author":"Hung","year":"2018","journal-title":"BMC Psychiatr"},{"issue":"3","key":"10.1016\/j.smrv.2020.101339_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jad.2011.05.014","article-title":"Sleep America: managing the crisis of adult chronic insomnia and associated conditions","volume":"138","author":"Kraus","year":"2012","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.smrv.2020.101339_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jep.2018.09.004","article-title":"Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history","volume":"227","author":"Bonini","year":"2018","journal-title":"J\u00a0Ethnopharmacol"},{"issue":"3","key":"10.1016\/j.smrv.2020.101339_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/02791072.2013.805976","article-title":"The medicinal use of cannabis and cannabinoids\u2014an international cross-sectional survey on administration forms","volume":"45","author":"Hazekamp","year":"2013","journal-title":"J\u00a0Psychoact Drugs"},{"issue":"5","key":"10.1016\/j.smrv.2020.101339_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5694\/mja17.01247","article-title":"Medicinal cannabis in Australia, 2016: the cannabis as medicine survey (CAMS-16)","volume":"209","author":"Lintzeris","year":"2018","journal-title":"Med J Aust"},{"issue":"1433","key":"10.1016\/j.smrv.2020.101339_bib15","first-page":"29","article-title":"New Zealand Health Survey 2012\/13: characteristics of medicinal cannabis users","volume":"129","author":"Pledger","year":"2016","journal-title":"N\u00a0Z Med J"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/WNP.0000000000000617","article-title":"Therapeutic uses of cannabis on sleep disorders and related conditions","volume":"37","author":"Choi","year":"2020","journal-title":"J\u00a0Clin Neurophysiol"},{"issue":"9","key":"10.1016\/j.smrv.2020.101339_bib17","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd1495","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","author":"Di Marzo","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.smrv.2020.101339_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152473","article-title":"Endocannabinoid signaling regulates sleep stability","volume":"11","author":"Pava","year":"2016","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.smrv.2020.101339_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.5665\/sleep.5546","article-title":"Sleep restriction enhances the daily rhythm of circulating levels of endocannabinoid 2-arachidonoylglycerol","volume":"39","author":"Hanlon","year":"2016","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.smrv.2020.101339_bib20","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1476-5381.2010.00790.x","article-title":"Endocannabinoid signalling: has it got rhythm?","volume":"160","author":"Vaughn","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.smrv.2020.101339_bib21","doi-asserted-by":"crossref","first-page":"104471","DOI":"10.1016\/j.psyneuen.2019.104471","article-title":"Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide)","volume":"111","author":"Hanlon","year":"2020","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/jc.2014-3455","article-title":"Circadian rhythm of circulating levels of the endocannabinoid 2-arachidonoylglycerol","volume":"100","author":"Hanlon","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.smrv.2020.101339_bib23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1124\/jpet.119.262139","article-title":"Pharmacologic characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin -1-yl]methanone, a reversible, selective, and potent monoacylglycerol lipase inhibitor","volume":"372","author":"Wyatt","year":"2020","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2215-0366(18)30427-9","article-title":"Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial","volume":"6","author":"D'Souza","year":"2019","journal-title":"The Lancet Psychiatry"},{"issue":"8","key":"10.1016\/j.smrv.2020.101339_bib25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/sleep\/26.8.943","article-title":"Anandamide enhances extracellular levels of adenosine and induces sleep: an in\u00a0vivo microdialysis study","volume":"26","author":"Murillo-Rodriguez","year":"2003","journal-title":"Sleep"},{"issue":"6646","key":"10.1016\/j.smrv.2020.101339_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/37891","article-title":"Anandamide may mediate sleep induction","volume":"389","author":"Mechoulam","year":"1997","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.smrv.2020.101339_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0006-8993(98)00969-X","article-title":"Anandamide modulates sleep and memory in rats","volume":"812","author":"Murillo-Rodr\u0131guez","year":"1998","journal-title":"Brain Res"},{"issue":"10","key":"10.1016\/j.smrv.2020.101339_bib28","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1097\/00001756-200107200-00018","article-title":"Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor","volume":"12","author":"Murillo-Rodr\u00edguez","year":"2001","journal-title":"Neuroreport"},{"issue":"20","key":"10.1016\/j.smrv.2020.101339_bib29","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despr\u00e9s","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.smrv.2020.101339_bib30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"J\u00a0Am Med Assoc"},{"issue":"9548","key":"10.1016\/j.smrv.2020.101339_bib31","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0140-6736(06)69571-8","article-title":"Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study","volume":"368","author":"Scheen","year":"2006","journal-title":"Lancet"},{"issue":"9468","key":"10.1016\/j.smrv.2020.101339_bib32","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.smrv.2020.101339_bib33","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.pnpbp.2008.04.008","article-title":"The role of the CB1 receptor in the regulation of sleep","volume":"32","author":"Murillo-Rodr\u00edguez","year":"2008","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatr"},{"issue":"10","key":"10.1016\/j.smrv.2020.101339_bib34","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/bph.14440","article-title":"Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors","volume":"176","author":"Tham","year":"2019","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.smrv.2020.101339_bib35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u03949-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"14","key":"10.1016\/j.smrv.2020.101339_bib36","doi-asserted-by":"crossref","first-page":"8711","DOI":"10.1074\/jbc.M114.618447","article-title":"Fatty acid-binding proteins (FABPs) are intracellular carriers for \u03949-tetrahydrocannabinol (THC) and cannabidiol (CBD)","volume":"290","author":"Elmes","year":"2015","journal-title":"J Biol Chem."},{"key":"10.1016\/j.smrv.2020.101339_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejim.2018.01.003","article-title":"The therapeutic effects of cannabis and cannabinoids: an update from the national academies of sciences, engineering and medicine report","volume":"48","author":"Abrams","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.smrv.2020.101339_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11920-017-0775-9","article-title":"Cannabis, cannabinoids, and sleep: a review of the literature","volume":"19","author":"Babson","year":"2017","journal-title":"Curr Psychiatr Rep"},{"issue":"6","key":"10.1016\/j.smrv.2020.101339_bib39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.smrv.2014.02.005","article-title":"The effects of cannabinoid administration on sleep: a systematic review of human studies","volume":"18","author":"Gates","year":"2014","journal-title":"Sleep Med Rev"},{"issue":"4","key":"10.1016\/j.smrv.2020.101339_bib40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1037\/pha0000285","article-title":"The use of cannabinoids for sleep: a critical review on clinical trials","volume":"27","author":"Kuhathasan","year":"2019","journal-title":"Exp Clin Psychopharmacol"},{"issue":"4","key":"10.1016\/j.smrv.2020.101339_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2010","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.smrv.2020.101339_bib42","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0031-9384(79)90263-4","article-title":"REM sleep deprivation increases aggressiveness in male rats","volume":"22","author":"Hicks","year":"1979","journal-title":"Physiol Behav"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.smrv.2020.101339_bib44","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.smrv.2020.101339_bib45","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.sleep.2017.04.019","article-title":"Cannabis for restless legs syndrome: a report of six patients","volume":"36","author":"Megelin","year":"2017","journal-title":"Sleep Med"},{"issue":"10","key":"10.1016\/j.smrv.2020.101339_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111412","article-title":"Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats","volume":"9","author":"Calik","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12952-016-0052-1","article-title":"Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats","volume":"15","author":"Calik","year":"2016","journal-title":"J\u00a0Negat Results Biomed"},{"key":"10.1016\/j.smrv.2020.101339_bib48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.resp.2013.10.001","article-title":"Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat","volume":"190","author":"Calik","year":"2014","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.smrv.2020.101339_bib49","series-title":"Effects of dronabinol on vagally mediated respiratory reflexes and upper airway motor output","year":"2012"},{"issue":"9","key":"10.1016\/j.smrv.2020.101339_bib50","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx112","article-title":"Effects of cannabinoid agonists and antagonists on sleep and breathing in Sprague-Dawley rats","volume":"40","author":"Calik","year":"2017","journal-title":"Sleep"},{"issue":"4","key":"10.1016\/j.smrv.2020.101339_bib51","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/sleep\/25.4.388","article-title":"Functional role for cannabinoids in respiratory stability during sleep","volume":"25","author":"Carley","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2020.101339_bib52","article-title":"Peripheral cannabinoid receptor agonists chromenopyrazole 13a and HU-308 attenuate sleep apneas in rats","volume":"38","author":"Topchiy","year":"2015","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2020.101339_bib53","first-page":"769463","article-title":"DMSO potentiates the suppressive effect of dronabinol, a cannabinoid, on sleep apnea and REM sleep","author":"Calik","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.smrv.2020.101339_bib54","series-title":"Activation of nodose ganglion cannabinoid receptors potentiates upper airway muscle activation","author":"Carley","year":"2015"},{"key":"10.1016\/j.smrv.2020.101339_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2013.00001","article-title":"Proof of concept trial of dronabinol in obstructive sleep apnea","volume":"4","author":"Prasad","year":"2013","journal-title":"Front Psychiatr"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsx184","article-title":"Pharmacotherapy of apnea by cannabimimetic enhancement, the PACE clinical trial: effects of dronabinol in obstructive sleep apnea","volume":"41","author":"Carley","year":"2018","journal-title":"Sleep"},{"key":"10.1016\/j.smrv.2020.101339_bib57","series-title":"A\u00a0study to examine the efficacy of a therapeutic THX-110 for obstructive sleep apnea","author":"ClinicalTrialsgov","year":"2018"},{"key":"10.1016\/j.smrv.2020.101339_bib58","author":"ANZCTR"},{"issue":"18","key":"10.1016\/j.smrv.2020.101339_bib59","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/WNR.0000000000000287","article-title":"2-Arachidonoylglycerol into the lateral hypothalamus improves reduced sleep in adult rats subjected to maternal separation","volume":"25","author":"P\u00e9rez-Morales","year":"2014","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.smrv.2020.101339_bib60","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pbb.2012.08.028","article-title":"Oleamide restores sleep in adult rats that were subjected to maternal separation","volume":"103","author":"Prieto","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.smrv.2020.101339_bib61","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0306-4522(03)00339-7","article-title":"Potential role of the cannabinoid receptor CB1 in rapid eye movement sleep rebound","volume":"120","author":"Navarro","year":"2003","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib62","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2011.08.013","article-title":"Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats","volume":"62","author":"Hsiao","year":"2012","journal-title":"Neuropharmacology"},{"issue":"S1","key":"10.1016\/j.smrv.2020.101339_bib63","doi-asserted-by":"crossref","DOI":"10.1002\/j.1552-4604.1981.tb02622.x","article-title":"Hypnotic and antiepileptic effects of cannabidiol","volume":"21","author":"Carlini","year":"1981","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.smrv.2020.101339_bib64","doi-asserted-by":"crossref","DOI":"10.7812\/TPP\/18-041","article-title":"Cannabidiol in anxiety and sleep: a large case series","volume":"23","author":"Shannon","year":"2019","journal-title":"Perm J"},{"issue":"4","key":"10.1016\/j.smrv.2020.101339_bib65","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7812\/TPP\/16-005","article-title":"Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder: a case report","volume":"20","author":"Shannon","year":"2016","journal-title":"Perm J"},{"issue":"2","key":"10.1016\/j.smrv.2020.101339_bib66","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1213\/ANE.0b013e3181c76f70","article-title":"The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial","volume":"110","author":"Ware","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.smrv.2020.101339_bib67","article-title":"Does cannabinoid really improve sleep? Testing the sleep effects of nabilone in chronic pain patients: a placebo-controlled, randomized, pilot study","volume":"84","author":"Zalai","year":"2015","journal-title":"Psychother Psychosom"},{"issue":"4","key":"10.1016\/j.smrv.2020.101339_bib68","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF00437513","article-title":"(\u2212) \u03b4 9 THC as an hypnotic","volume":"33","author":"Cousens","year":"1973","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.smrv.2020.101339_bib69","author":"ANZCTR"},{"key":"10.1016\/j.smrv.2020.101339_bib70","series-title":"Investigation of the efficacy and safety of CHI-921 in insomnia","author":"ClinicalTrialsgov","year":"2019"},{"key":"10.1016\/j.smrv.2020.101339_bib71","series-title":"A\u00a0trial to evaluate an oral medicinal cannabis extract compared with placebo for the treatment of insomnia Australian New Zealand Clinical Trials Registry","author":"ANZCTR","year":"2019"},{"issue":"9","key":"10.1016\/j.smrv.2020.101339_bib73","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/1871527318666191021143300","article-title":"Cannabidiol partially blocks the sleepiness in hypocretin-deficient rats. Preliminary data","volume":"18","author":"Murillo-Rodr\u00edguez","year":"2019","journal-title":"CNS & Neurological Disorders Drug Targets"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib74","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1755-5949.2008.00071.x","article-title":"The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD)","volume":"15","author":"Fraser","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.smrv.2020.101339_bib75","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: a preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.smrv.2020.101339_bib76","first-page":"564","article-title":"Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series","volume":"39","author":"Chagas","year":"2014","journal-title":"J\u00a0Clin Pharm Therapeut"},{"issue":"10","key":"10.1016\/j.smrv.2020.101339_bib77","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1161\/01.CIR.0000158823.53941.BE","article-title":"Clinical trial registration: a statement from the international committee of medical journal","volume":"111","author":"De Angelis","year":"2005","journal-title":"Circulation"},{"issue":"1\u20132","key":"10.1016\/j.smrv.2020.101339_bib78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.resp.2008.06.021","article-title":"Pharmacology of vagal afferent influences on disordered breathing during sleep","volume":"164","author":"Carley","year":"2008","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.smrv.2020.101339_bib79","author":"ClinicalTrialsgov"},{"issue":"4","key":"10.1016\/j.smrv.2020.101339_bib80","doi-asserted-by":"crossref","first-page":"679","DOI":"10.5664\/jcsm.7070","article-title":"Medical cannabis and the treatment of obstructive sleep apnea: an American Academy of Sleep Medicine position statement","volume":"14","author":"Ramar","year":"2018","journal-title":"J\u00a0Clin Sleep Med"},{"key":"10.1016\/j.smrv.2020.101339_bib81","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.smrv.2016.10.002","article-title":"Phenotypes in obstructive sleep apnea: a definition, examples and evolution of approaches","volume":"35","author":"Zinchuk","year":"2017","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.smrv.2020.101339_bib83","author":"Organisation Wh"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib84","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/08897077.2015.1023484","article-title":"Cannabis withdrawal and sleep: a systematic review of human studies","volume":"37","author":"Gates","year":"2016","journal-title":"Subst Abuse"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib85","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2011.01.003","article-title":"Sleep disturbance and the effects of extended-release zolpidem during cannabis withdrawal","volume":"117","author":"Vandrey","year":"2011","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.smrv.2020.101339_bib86","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jsat.2012.08.224","article-title":"Poor sleep quality as a risk factor for lapse following a cannabis quit attempt","volume":"44","author":"Babson","year":"2013","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib87","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drugalcdep.2006.04.014","article-title":"Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms","volume":"86","author":"Budney","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20132","key":"10.1016\/j.smrv.2020.101339_bib88","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.drugalcdep.2012.08.001","article-title":"The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users","volume":"128","author":"Vandrey","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.smrv.2020.101339_bib89","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/cbdv.200790150","article-title":"Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex\u00ae, a cannabis-based medicine","volume":"4","author":"Russo","year":"2007","journal-title":"Chem Biodivers"},{"issue":"3","key":"10.1016\/j.smrv.2020.101339_bib90","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.euroneuro.2013.10.012","article-title":"Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience","volume":"24","author":"Foga\u00e7a","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"issue":"12","key":"10.1016\/j.smrv.2020.101339_bib91","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"10.1016\/j.smrv.2020.101339_bib92","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/epi.13060","article-title":"Drug\u2013drug interaction between clobazam and cannabidiol in children with refractory epilepsy","volume":"56","author":"Geffrey","year":"2015","journal-title":"Epilepsia"},{"issue":"9","key":"10.1016\/j.smrv.2020.101339_bib93","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/epi.13852","article-title":"Interactions between cannabidiol and commonly used antiepileptic drugs","volume":"58","author":"Gaston","year":"2017","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.smrv.2020.101339_bib94","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A\u00a0phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.smrv.2020.101339_bib95","doi-asserted-by":"crossref","first-page":"107937","DOI":"10.1016\/j.drugalcdep.2020.107937","article-title":"Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users","volume":"211","author":"Spindle","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.smrv.2020.101339_bib96","series-title":"Zelira Therapeutics achieves primary endpoints of medicinal cannabis trial for insomnia","author":"ProactiveInvestors","year":"2020"},{"issue":"suppl 1","key":"10.1016\/j.smrv.2020.101339_bib97","first-page":"S87","article-title":"Restless legs syndrome: treatment with dopaminergic agents","volume":"58","author":"Comella","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib98","first-page":"81","article-title":"Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study","volume":"33","author":"Cornelius","year":"2010","journal-title":"Sleep"},{"issue":"18","key":"10.1016\/j.smrv.2020.101339_bib99","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1016\/j.febslet.2006.04.102","article-title":"Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats","volume":"580","author":"Murillo-Rodr\u00edguez","year":"2006","journal-title":"FEBS (Fed Eur Biochem Soc) Lett"},{"issue":"6","key":"10.1016\/j.smrv.2020.101339_bib100","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1037\/a0013278","article-title":"The nonpsychoactive Cannabis constituent cannabidiol is a wake-inducing agent","volume":"122","author":"Murillo-Rodr\u00edguez","year":"2008","journal-title":"Behav Neurosci"},{"issue":"3","key":"10.1016\/j.smrv.2020.101339_bib101","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/1570159X11666131204235805","article-title":"Potential effects of cannabidiol as a wake-promoting agent","volume":"12","author":"Murillo-Rodr\u00edguez","year":"2014","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.smrv.2020.101339_bib102","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fnmol.2017.00152","article-title":"Role of N-Arachidonoyl-Serotonin (AA-5-HT) in sleep-wake cycle architecture, sleep homeostasis, and neurotransmitters regulation","volume":"10","author":"Murillo-Rodr\u00edguez","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.smrv.2020.101339_bib103","series-title":"Handbook of experimental pharmacology","doi-asserted-by":"crossref","DOI":"10.1007\/164_2018_95","article-title":"Dopamine and wakefulness: pharmacology, genetics, and circuitry","author":"Wisor","year":"2018"},{"issue":"2","key":"10.1016\/j.smrv.2020.101339_bib104","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jat\/bkx012","article-title":"Pharmacokinetic profile of oral cannabis in humans: blood and oral fluid disposition and relation to pharmacodynamic outcomes","volume":"41","author":"Vandrey","year":"2017","journal-title":"J\u00a0Anal Toxicol"},{"issue":"8","key":"10.1016\/j.smrv.2020.101339_bib105","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/add.13347","article-title":"The effects of cannabis intoxication on motor vehicle collision revisited and revised","volume":"111","author":"Rogeberg","year":"2016","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.smrv.2020.101339_bib106","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s00213-019-05246-8","article-title":"Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition","volume":"236","author":"Arkell","year":"2019","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.smrv.2020.101339_bib107","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a Cannabis sativa constituent","volume":"6","author":"Machado Bergamaschi","year":"2011","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.smrv.2020.101339_bib108","doi-asserted-by":"crossref","first-page":"106938","DOI":"10.1016\/j.yebeh.2020.106938","article-title":"Abrupt withdrawal of cannabidiol (CBD): a randomized trial","volume":"104","author":"Taylor","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.smrv.2020.101339_bib109","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14740338.2017.1397128","article-title":"Drug-drug interactions as a result of co-administering \u03949-THC and CBD with other psychotropic agents","volume":"17","author":"Rong","year":"2018","journal-title":"Expet Opin Drug Saf"},{"issue":"8","key":"10.1016\/j.smrv.2020.101339_bib110","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/jcph.1412","article-title":"A\u00a0phase 1, open-label, parallel-group, single-dose trial of the pharmacokinetics and safety of cannabidiol (CBD) in subjects with mild to severe hepatic impairment","volume":"59","author":"Taylor","year":"2019","journal-title":"J\u00a0Clin Pharmacol"}],"container-title":["Sleep Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079220300824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1087079220300824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:28:04Z","timestamp":1761067684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1087079220300824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":108,"alternative-id":["S1087079220300824"],"URL":"https:\/\/doi.org\/10.1016\/j.smrv.2020.101339","relation":{},"ISSN":["1087-0792"],"issn-type":[{"value":"1087-0792","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smrv.2020.101339","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101339"}}